Abiopharma

🔍 MOYNIHAN BRIAN T (Director)

Company: BANK OF AMERICA CORP /DE/ (BAC)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 18,083 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,717,695.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 18,083 shares of Common Stock at $54.32 per share (Direct)
  Date: 2026-04-15 | Code: D | equity_swap_involved: 0 | shares_owned_after: 2,699,612.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: H | nature_of_ownership: 401(k) Plan | shares_owned_after: 3,613.62 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 100,000.00
• Sold 18,083 shares of 2026 Cash Settled Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2027-02-15 | equity_swap_involved: 0 | shares_owned_after: 180,829.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3

Footnotes:

• F1: Each unit is the economic equivalent of one share of Bank of America Corporation common stock.
• F2: The share equivalents attributed to the reporting person's 401(k) balance increased 30.135 shares due to dividend reinvestments and changes in the Net Asset Value (NAV) of the issuer's stock fund.
• F3: On February 13, 2026, the reporting person was granted units, vesting and payable solely in cash as follows: 1/12th of the stock units vest and become payable on the 15th day of each month during the 12-month period beginning in March 2026 and ending in February 2027.